Clinical PictureHIV-associated psoriasis
References (0)
Cited by (13)
HIV-Associated Psoriasis
2018, Actas Dermo-SifiliograficasPsoriasis in patients with HIV infection: From the Medical Board of the National Psoriasis Foundation
2010, Journal of the American Academy of DermatologyCitation Excerpt :The therapy not only controls the progression of HIV but may also effectively treat HIV-associated psoriasis, which often occurs at CD4 counts below 350 cells/mm3. Improvement of HIV-associated psoriasis after the initiation of highly active antiretroviral therapy has been reported in several case reports.14-17 Antiretrovirals such as zidovudine have been investigated as psoriatic therapy in both the HIV and non-HIV population.14,38
A series of critically challenging case scenarios in moderate to severe psoriasis: A Delphi consensus approach
2009, Journal of the American Academy of DermatologyCitation Excerpt :Although HIV and AIDS are serious healthcare concerns, there are very limited evidence-based data that support treatment options for psoriasis patients who have HIV or AIDS. It should be emphasized that effective control of HIV infection using the currently recommended antiretroviral therapies often ameliorates psoriasis in these patients.12-15 For this reason, the use of highly active anti-retroviral therapies (HAART) often is considered “first-line” therapy for psoriasis in HIV-infected patients.
Psoriasis and hiv infection
2008, Actas Dermo-SifiliograficasRisankizumab, a therapeutic alternative for psoriasis in people living with HIV
2024, Journal of International Medical ResearchDermatologic manifestations of HIV infection
2018, The Sub-Specialty Care of HIV-Infected Patients